242 related articles for article (PubMed ID: 29312223)
1. A 5-year Survey Reveals Increased Susceptibility to Glycopeptides for Methicillin-Resistant
Jiang B; Yin S; You B; Huang G; Yang Z; Zhang Y; Chen Y; Chen J; Yuan Z; Rao X; Hu X; Gong Y; Peng Y
Front Microbiol; 2017; 8():2531. PubMed ID: 29312223
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin, teicoplanin, daptomycin, and linezolid MIC creep in methicillin-resistant Staphylococcus aureus is associated with clonality.
Hsieh YC; Lin YC; Huang YC
Medicine (Baltimore); 2016 Oct; 95(41):e5060. PubMed ID: 27741120
[TBL] [Abstract][Full Text] [Related]
3. Glycopeptide and daptomycin susceptibility trends among clinical isolates of methicillin-resistant Staphylococcus aureus in a tertiary care center in North India.
Singh A; Prasad KN; Rai RP; Singh SK; Rahman M; Tripathi A; Srivastava JK
J Infect Public Health; 2015; 8(4):341-5. PubMed ID: 25797814
[TBL] [Abstract][Full Text] [Related]
4. A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy.
Cojutti P; Scarparo C; Sartor A; Coato P; Rigoli R; Pea F
Diagn Microbiol Infect Dis; 2015 Jan; 81(1):53-6. PubMed ID: 25301716
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.
Kao TM; Wang JT; Weng CM; Chen YC; Chang SC
J Microbiol Immunol Infect; 2011 Oct; 44(5):346-51. PubMed ID: 21524980
[TBL] [Abstract][Full Text] [Related]
6. Comparative activity of oritavancin against meticillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Geneva University Hospital.
Vaudaux P; Huggler E; Arhin FF; Moeck G; Renzoni A; Lew DP
Int J Antimicrob Agents; 2009 Dec; 34(6):540-3. PubMed ID: 19744838
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
Steinkraus G; White R; Friedrich L
J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin, linezolid and daptomycin susceptibility pattern among clinical isolates of methicillin-resistant
Husain A; Rawat V; Umesh ; Kumar M; Verma PK
J Lab Physicians; 2018; 10(2):145-148. PubMed ID: 29692578
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus.
Falcón R; Mateo E; Oltra R; Giménez E; Albert E; Torres I; Navarro D
Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):903-912. PubMed ID: 30729396
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Activity of Vancomycin, Teicoplanin, Linezolid and Daptomycin Against Methicillin-Resistant
Xu Y; Wang B; Zhao H; Wang X; Rao L; Ai W; Yu J; Guo Y; Wu X; Yu F; Chen S
Infect Drug Resist; 2021; 14():5449-5456. PubMed ID: 34949928
[TBL] [Abstract][Full Text] [Related]
11. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2018.
Coombs GW; Daley DA; Mowlaboccus S; Lee YT; Pang S;
Commun Dis Intell (2018); 2020 Mar; 44():. PubMed ID: 32178604
[TBL] [Abstract][Full Text] [Related]
12. Minimum Inhibitory Concentrations of Vancomycin and Daptomycin Against Methicillin-resistant Staphylococcus Aureus Isolated from Various Clinical Specimens: A Study from South India.
Moses VK; Kandi V; Rao SKD
Cureus; 2020 Jan; 12(1):e6749. PubMed ID: 32140317
[TBL] [Abstract][Full Text] [Related]
13. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2017.
Coombs GW; Daley DA; Lee YT; Pang S
Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522665
[TBL] [Abstract][Full Text] [Related]
14. An investigation of vancomycin minimum inhibitory concentration creep among methicillin-resistant Staphylococcus aureus strains isolated from pediatric patients and healthy children in Northern Taiwan.
Chang CN; Lo WT; Chan MC; Yu CM; Wang CC
J Microbiol Immunol Infect; 2017 Jun; 50(3):362-369. PubMed ID: 26297168
[TBL] [Abstract][Full Text] [Related]
15. [In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates to vancomycin, teicoplanin, linezolide and daptomycin].
Celikbilek N; Ozdem B; Gürelik FC; Güvenman S; Güner HR; Açıkgöz ZC
Mikrobiyol Bul; 2011 Jul; 45(3):512-8. PubMed ID: 21935784
[TBL] [Abstract][Full Text] [Related]
16. Genotyping of Methicillin Resistant Staphylococcus aureus from Tertiary Care Hospitals in Coimbatore, South India.
Neetu TJ; Murugan S
J Glob Infect Dis; 2016; 8(2):68-74. PubMed ID: 27293361
[TBL] [Abstract][Full Text] [Related]
17. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of antibiotic resistance patterns and reduced vancomycin susceptibilities of methicillin-resistant Staphylococcus aureus isolates: a multi-center study].
Çıkman A; Aydın M; Gülhan B; Parlak M; Gültepe B; Kalaycı Y; Bayındır Bilmen F; Solmaz S; Özekinci T
Mikrobiyol Bul; 2015 Apr; 49(2):240-8. PubMed ID: 26167824
[TBL] [Abstract][Full Text] [Related]
19. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]